Fidelity Advisor Biotechnology Fund MRUS Holdings History
Fidelity Advisor Biotechnology Fund's Merus NV Holding Summary
As of 2025-04-30, FIDELITY ADVISOR SERIES VII held 73,200.00 shares of Merus NV(MRUS), totaling $1.39 Mil. This investment constitutes 0.1% of their stock portfolio, and FIDELITY ADVISOR SERIES VII now holds 0.1% of the outstanding Merus NV(MRUS) stock.
The initial trade took place in 2024Q2. And since then Fidelity Advisor Biotechnology Fund has made 3 purchases of MRUS, at an average price of $47.38, for a total of 1.14 Mil shares. In addition, there have been 2 sales at an average price of $47.00 for 1.07 Mil shares. Based on historical transaction data and MRUS's current price of $63.26, Fidelity Advisor Biotechnology Fund's estimated gain on his MRUS holdings is $761,915.00, reflecting a 1.41% gain to date.
Fidelity Advisor Biotechnology Fund MRUS ($63.26) Holding Chart
Fidelity Advisor Biotechnology Fund MRUS ($63.26) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1